Choose language
Do you want to set the chosen language as default?
Yes, set as default
Search
Trending Topics
Stock

Amazon

 Stock

Apple

 Stock

Alphabet

 Stock

SpaceX

 Commodities

Oil prices

 Asset

ETFs

Stocks

See all

ETFs

See all

Cryptocurrencies

See all

Tools

ALT

Altimmune Inc.

Price

$2.95

return (12m)

-18.20% Logo

p/e

-3.81

p/bv

1.22

DIVIDEND YIELD

0.00%
graph

ALT price

Select period
Select period
Altimmune
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment ALT

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
-6.56%
3 months
-2.23%
1 year
-18.20%
2 years
-50.79%
5 years
-69.68%
10 years
-99.09%
Fundamental indicators

Fundamentals ALT

Check the fundamentals of Altimmune shares.

Valuation

P/E
-3.81
Sector -3.98
Industry -3.98
P/BV
1.22
Sector 2.00
Industry 2.00
P/Revenue (PSR)
-
Sector -4.41
Industry -4.41
EV/EBITDA
-2.34
Sector -245.01
Industry -245.01
EV/EBIT
-2.33
Sector -666.51
Industry -666.51
P/EBITDA
-3.93
Sector -4.07
Industry -4.07
P/EBIT
-3.93
Sector -4.24
Industry -4.24
P/Total Assets
1.03
Sector 1.40
Industry 1.40
P/Net Current Assets
1.23
Sector -11.65
Industry -11.65
P/Working Capital
1.07
Sector -10.95
Industry -10.95
EPS
-0.73
Sector -2.20
Industry -2.20
BVPS
2.29
Sector 1.95
Industry 1.95

Efficiency

Gross Margin
100.00%
Sector 36.05%
Industry 36.05%
EBITDA Margin
-
Sector -16,817.20%
Industry -16,817.20%
EBIT Margin
-
Sector -4,256,841.62%
Industry -4,256,841.62%
Operating Margin
-100.00%
Sector -38.74%
Industry -38.74%
Net Profit Margins
-100.00%
Sector -39.50%
Industry -39.50%
Asset Turnover
0.00
Sector 0.03
Industry 0.03

Profitability

ROE
-32.07%
Sector -66.41%
Industry -66.41%
ROA
-27.14%
Sector -66.55%
Industry -66.55%
ROIC
-6,038.36%
Sector -1,703.97%
Industry -1,703.97%

Dividends

Dividend yield
0.00%
Sector -
Industry -
Payout
-
Sector -
Industry -

Debt

Current Ratio
29.57
Sector 2.90
Industry 2.90
Net Debt / EBITDA
13.83
Sector -14.63
Industry -14.63
Net Debt / EBIT
13.82
Sector -7.24
Industry -7.24
Net Debt / Equity
-1.05
Sector -33,201.65
Industry -33,201.65
Gross Debt / Equity
0.12
Sector -0.02
Industry -0.02
Equity/Assets
0.85
Sector 0.42
Industry 0.42
Liabilities/Assets
0.15
Sector 0.39
Industry 0.39

Growth

5Y Revenue CAGR
-63.16%
Sector -
Industry -
5Y Earnings CAGR
-1.27%
Sector -
Industry -
Histórico de indicadores fundamentalistas

Fundamentals ALT

Buy And Hold Investor Checklist

Altimmune Buy And Hold Investor Checklist


This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]

Stock Comparison Tool

graph

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Price

ALT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

ABOUT

Logo Altimmune

Altimmune Inc.

Average Investor10 user rating

4.0 (1 people)

United States

United States

21 years

Founded: 2005

2005

Time since IPO - 21 years

43

Employees

Market cap

$347.20 million

$347.20 million

Net worth

$283.99 million

$283,990,000.00

Assets

$335.63 million

$335,630,000.00

Total Shares Outstanding

124.00 million

124,000,000

Average Daily Trading Volume

$4.09 million

$4,087,092.00

Sector

Health Care

Industry

Biotechnology

Shares

ALT
receitas e lucros

ALT revenue and profits

graph

PROFIT X PRICE ALT

Financials

Financial Results ALT

DRAG THE FRAME TO SEE MORE DATA
Financials

ALT cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - ALT

Pontos Relevantes

ALT balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more assets
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12M)
P/E

0.00

DY

0.00%

ROE

-893.55%

P/BV

0.00
Logo McKesson

MCK - McKesson

$847.31 21,88% (12M)
P/E

22.00

DY

0.38%

ROE

-570.98%

P/BV

-125.59
Logo Cardinal Health

CAH - Cardinal Health

$232.10 50,34% (12M)
P/E

34.61

DY

0.89%

ROE

-58.20%

P/BV

-20.14
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$252.98 55,77% (12M)
P/E

29.40

DY

2.04%

ROE

24.76%

P/BV

7.28
Logo AbbVie

ABBV - AbbVie

$245.58 30,93% (12M)
P/E

71.07

DY

2.66%

ROE

-%

P/BV

0.00
Logo Merck & Co.

MRK - Merck & Co.

$127.32 66,98% (12M)
P/E

35.97

DY

2.58%

ROE

19.45%

P/BV

7.00
Logo AstraZeneca

AZN - AstraZeneca

$154.46 6,01% (12M)
P/E

25.16

DY

1.89%

ROE

20.74%

P/BV

5.22
Logo Novo Nordisk

NVO - Novo Nordisk

$46.60 0,09% (12M)
P/E

11.00

DY

3.96%

ROE

60.40%

P/BV

6.65
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12 M)
P/L

0.00

DY

0.00%

ROE

-893.55%

P/VP

0.00
Logo McKesson

MCK - McKesson

$847.31 21,88% (12 M)
P/L

22.00

DY

0.38%

ROE

-570.98%

P/VP

-125.59
Logo Cardinal Health

CAH - Cardinal Health

$232.10 50,34% (12 M)
P/L

34.61

DY

0.89%

ROE

-58.20%

P/VP

-20.14
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$252.98 55,77% (12 M)
P/L

29.40

DY

2.04%

ROE

24.76%

P/VP

7.28
Logo AbbVie

ABBV - AbbVie

$245.58 30,93% (12 M)
P/L

71.07

DY

2.66%

ROE

-%

P/VP

0.00
Logo Merck & Co.

MRK - Merck & Co.

$127.32 66,98% (12 M)
P/L

35.97

DY

2.58%

ROE

19.45%

P/VP

7.00
Logo AstraZeneca

AZN - AstraZeneca

$154.46 6,01% (12 M)
P/L

25.16

DY

1.89%

ROE

20.74%

P/VP

5.22
Logo Novo Nordisk

NVO - Novo Nordisk

$46.60 0,09% (12 M)
P/L

11.00

DY

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Altimmune (ALT) today?

A cotação de Altimmune (ALT) hoje está em US$ 2.95, com uma variação de -18.2% em relação ao último ano. A cotação de Altimmune (ALT) iniciou o ano negociando na casa dos US$ 3.61 e hoje está em US$ 2.95. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Altimmune (ALT) e dados de ações do Ibovespa e mercados internacionais.

Quando Altimmune (ALT) paga dividendos?

Altimmune (ALT) não distribuiu dividendos no último ano.

Is Altimmune (ALT) a good investment?

Atualmente, Altimmune (ALT) está cotada a US$ 2.95, com um P/L de -3.81, representando um desvio de -617% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -18.2 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -18.20%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Altimmune (ALT) stock?

Investir em ações de Altimmune (ALT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Altimmune (ALT) yield today?

A rentabilidade de Altimmune (ALT) foi de -6.56% no último mês, -18.20% no último ano e -69.68% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Altimmune (ALT) hoje, o investimento total seria de US$ 295.28, com base na cotação atual de US$ 2.95.

Based on historical performance, the investment would have grown to approximately:

  • Em 1 ano: US$ 241.54
  • Em 5 anos: US$ 89.53
  • Em 10 anos: US$ 2.69

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.